Vaxcyte, Inc. Common Stock
PCVX Real Time Price USDRecent trades of PCVX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by PCVX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Periodontitis vaccine and related compositions and methods of use Oct. 22, 2024
-
Patent Title: Polypeptide-antigen conjugates with non-natural amino acids Jun. 04, 2024
-
Patent Title: Conjugated vaccine carrier proteins Apr. 09, 2024
-
Patent Title: Periodontitis vaccine and related compositions and methods of use Jul. 18, 2023
-
Patent Title: Periodontitis vaccine and related compositions and methods of use Nov. 17, 2020
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of PCVX in WallStreetBets Daily Discussion
Recent insights relating to PCVX
Recent picks made for PCVX stock on CNBC
ETFs with the largest estimated holdings in PCVX
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PCVX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.